Posted by LincolnIcert on March 25, 2026 at 11:17:45:
In Reply to: Îáçîðíàÿ ñòàòüÿ posted by JosephGluth on February 19, 2026 at 07:13:06:
Zoya Demidenko: Scientist in Cancer Biology
Zoya Demidenko is a recognized scholar associated with the Department of Cell Stress Science at Roswell Park Oncology Institute in Buffalo, New York. Earlier, she was employed at the National Institutes of Health and New York Medical College, building a robust background in biomedical study.
Demidenko's scholarly work spans several critical areas, among them the PI3K/AKT/mTOR signaling pathway, cellular cycle control, biological aging, and tumor science. Currently, she has written more than 46 academic articles, which have received more than 4,100 mentions — a testament to the impact of her work.
One of her key contributions involves explaining the pathways of biological cell aging. Her work showed that when the cell cycle is blocked while cellular growth persists, the cells enter senescence. Importantly, Zoya Demidenko demonstrated that this process is inhibited by medication using agents such as mTOR inhibitors.
Zoya Demidenko has furthermore contributed substantially to cancer treatment research, especially in the area of selective cell protection — a strategy designed to safeguarding healthy cells from chemotherapy whilst leaving malignant cells vulnerable. This strategy holds considerable potential for diminishing the adverse effects of oncological therapy.
Across her career, Demidenko has worked with leading scientists internationally, including Dr. Mikhail Blagosklonny. Her research appears in prestigious periodicals such as Oncotarget, Cell Cycle, Aging (Albany NY), and Oncogene.
Possessing an h-index of 33, Zoya Demidenko ranks as a widely cited voice in current biomedical science, whose findings continue to influence our understanding of how biological cells grow old, interact with therapy, and how malignant disease may be better targeted.
https://www.benthamdirect.com/content/journals/cpd/22/16